| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/08/2001 | EP1121121A2 Methods for inhibiting diabetic complications |
| 08/08/2001 | EP1121119A1 A new composition |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121113A1 Methods for regulating bone formation |
| 08/08/2001 | EP1121108A2 Novel therapeutic use of compounds with beta-3-agonist activity |
| 08/08/2001 | EP1121102A1 Liposome-entrapped topoisomerase inhibitors |
| 08/08/2001 | EP1121064A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 08/08/2001 | EP0965342B1 Preparation for percutaneous administration containing 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole |
| 08/08/2001 | EP0960118A4 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 08/08/2001 | EP0766682B1 Protein kinase c inhibitors |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1307590A Treating and diagnosing macrophage-mediated diseases using FC receptor ligands |
| 08/08/2001 | CN1307588A Compounds with growth hormone releasing properties |
| 08/08/2001 | CN1307584A Macrolide LHRH antagonists |
| 08/08/2001 | CN1307576A Serotongergic agents |
| 08/08/2001 | CN1307575A New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/08/2001 | CN1307574A Indolyl derivatives as serotonergic agents |
| 08/08/2001 | CN1307573A Indolyl derivatives and serotonergic agents |
| 08/08/2001 | CN1307567A 1,5 benzodiazepine derivatives |
| 08/08/2001 | CN1307566A Pyrazoline derivatives, their prep. and application as medicaments |
| 08/08/2001 | CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 08/08/2001 | CN1307562A Antipsychotic indolyl derivatives |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307560A Amidino and guanidino beta-azetidinone tryptase inhibitors |
| 08/08/2001 | CN1307484A Antibodies against human CD40 |
| 08/08/2001 | CN1307480A Fertility improving composition and application thereof |
| 08/08/2001 | CN1307473A Triterpene compositions and methods for use thereof |
| 08/08/2001 | CN1307471A Use of NMDA antagonists for treatment of irritable bowel syndrome |
| 08/08/2001 | CN1306858A Hemoglobin polymerizing agent |
| 08/08/2001 | CN1306838A Car sickness preventing beverage |
| 08/08/2001 | CN1306821A Application and usage of Miconazole cream |
| 08/08/2001 | CN1069321C New inhibitors of platelet aggregation |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069214C Stabilized somatotropin for parenteral administration |
| 08/08/2001 | CN1069208C Juice for tonifying kidney and nourishing stomach |
| 08/07/2001 | USRE37314 Pyrimidine derivatives |
| 08/07/2001 | US6271408 Process for making metabolites of lycopene |
| 08/07/2001 | US6271390 Suppression of the IgE-dependent allergic response by benzimidazole analogs |
| 08/07/2001 | US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271360 Single-stranded oligodeoxynucleotide mutational vectors |
| 08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271268 Treatment of gland disorders with antisecretory agents such as acyl coa cholesterol acyl transferase(acat) inhibitors or prodrugs |
| 08/07/2001 | US6271262 Metalloproteinase inhibitors |
| 08/07/2001 | US6271257 Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol |
| 08/07/2001 | US6271253 Cyclooxygenase inhibitors |
| 08/07/2001 | US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 08/07/2001 | US6271250 Metal Glycididaagolc, and preparation and uses thereof |
| 08/07/2001 | US6271249 Diphenyl imidazoles as potassium channel modulators |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271247 Binding to neuropeptide receptors |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271243 Pharmaceutical composition |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6271228 Blood pressure stabilization during hemodialysis |
| 08/07/2001 | US6271227 Anticoagulants |
| 08/07/2001 | US6271223 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 08/07/2001 | US6271217 Method of treating cancer with a benzimidazole and a chemotherapeutic agent |
| 08/07/2001 | US6271212 Mixture with carrier |
| 08/07/2001 | US6271015 A polypeptide having an amino acid sequence that hydrolysizes cis-9,10-octadecenoamide and other soporific fatty acid amides; therapy for sleep disorders and narcolepsy |
| 08/07/2001 | US6270995 A polypeptide that regulate nerve cell function and morphology; diagnosis and therapy for nervous system disorders |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270993 VEGF-binding polypeptide |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270984 Modulating robo: ligand interactions |
| 08/07/2001 | US6270811 Inactive culture of bacteria of the genus bifidobacterium compatible in cosmetics or pharmacy, in a mixture with an essential oil, and an organic acid. |
| 08/07/2001 | US6270770 Production losses can be prevented by a live attenuated caa vaccine for mucosal administration. |
| 08/07/2001 | US6270759 Method of using IL-11 for treating gingivitis |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | CA2104782C 1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines |
| 08/07/2001 | CA2092919C Epoxysuccinamic acid derivatives |
| 08/02/2001 | WO2001055725A2 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 08/02/2001 | WO2001055692A2 Neurosteroids as markers for alzheimer's disease |
| 08/02/2001 | WO2001055432A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055357A2 Myeloid colony stimulating factor and uses thereof |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055215A1 Therapeutic peptides |
| 08/02/2001 | WO2001055210A2 Human cyr61 |
| 08/02/2001 | WO2001055153A1 Clavams as protease inhibitors |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055150A1 4-heteroaryl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof |
| 08/02/2001 | WO2001055149A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 08/02/2001 | WO2001055148A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | WO2001055147A1 PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055133A1 Substituted tryptophan derivatives |
| 08/02/2001 | WO2001055132A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 08/02/2001 | WO2001055131A2 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055121A1 Azepine derivatives |
| 08/02/2001 | WO2001055120A1 Preparation of sulfonamides |
| 08/02/2001 | WO2001055116A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055114A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |